Artelo Biosciences, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $25.8M | $10.4M |
| Jun 2022 | — | $23.8M | $12.1M |
| Sep 2022 | — | $21.9M | $7.1M |
| Dec 2022 | — | $19.4M | $6.9M |
| Mar 2023 | — | $17.6M | $6.9M |
| Jun 2023 | — | $16.3M | $5.7M |
| Sep 2023 | — | $14.6M | $2.6M |
| Dec 2023 | — | $11.8M | $2.8M |
| Mar 2024 | — | $9.5M | $1.2M |
| Jun 2024 | — | $7.3M | $881.0K |
| Sep 2024 | — | $6.4M | $4.4M |
| Dec 2024 | — | $2.9M | $2.3M |
| Mar 2025 | — | $652.0K | $746.0K |
| Jun 2025 | — | $-1.4M | $2.1M |
| Sep 2025 | — | $-633.0K | $1.7M |
| Dec 2025 | — | $-1.3M | $600.0K |
| Mar 2026 | — | $6.7M | $4.2M |
| Jun 2026 | — | $5.0M | $4.2M |